0001193125-15-018922.txt : 20150123 0001193125-15-018922.hdr.sgml : 20150123 20150123163130 ACCESSION NUMBER: 0001193125-15-018922 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150123 DATE AS OF CHANGE: 20150123 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Intersect ENT, Inc. CENTRAL INDEX KEY: 0001271214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 200280837 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88513 FILM NUMBER: 15545905 BUSINESS ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-641-2100 MAIL ADDRESS: STREET 1: 1555 ADAMS DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: SINEXUS INC DATE OF NAME CHANGE: 20031124 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0425 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 SC 13G 1 d859913dsc13g.htm SC 13G SC 13G

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

Information to be included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

Intersect ENT, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

46071F103

(CUSIP Number)

December 31, 2014

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


SCHEDULE 13G

 

CUSIP No. 46071F103   Page 2 of 5 Pages

 

  (1)   

Names of reporting persons

 

Medtronic, Inc.

  (2)  

Check the appropriate box if a member of a group (see instructions)*

 

(a)  ¨        (b)  ¨

  (3)  

SEC use only

 

  (4)  

Citizenship or place of organization

 

MN

Number of

shares

beneficially

owned by

each

reporting

person

with

   (5)    

Sole voting power

 

1,202,443 (1)

   (6)   

Shared voting power

 

0

   (7)   

Sole dispositive power

 

1,202,443 (1)

   (8)   

Shared dispositive power

 

0

  (9)  

Aggregate amount beneficially owned by each reporting person

 

1,202,443 (1)

(10)  

Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

 

¨

(11)  

Percent of class represented by amount in Row (9)

 

5.1% (2)

(12)  

Type of reporting person (see instructions)

 

CO

 

(1) Represents Medtronic, Inc.’s ownership as of December 31, 2014. Includes options held by Medtronic, Inc. that are exercisable within 60 days to acquire 4,167 shares of common stock.
(2) The percentage is based upon 23,376,751 shares of common stock outstanding as reported on the Issuer’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, as filed with the Securities and Exchange Commission on November 10, 2014. The percentage includes 4,167 shares of common stock that may be acquired by Medtronic, Inc. upon the exercise of options exercisable within 60 days, which are deemed outstanding in accordance with Rule 13d-3(d)(1) under the Exchange Act.


CUSIP No. 46071F103    Page 3 of 5 Pages

 

Item 1(a) Name of Issuer:

Intersect ENT, Inc.

 

Item 1(b) Address of Issuer’s Principal Executive Offices:

1555 Adams Drive

Melno Park, CA 94025

 

Item 2(a) Name of Persons Filing:

Medtronic, Inc.

 

Item 2(b) Address of Principal Business Office or, if None, Residence:

710 Medtronic Parkway

Minneapolis, MN 55432

 

Item 2(c) Citizenship:

MN

 

Item 2(d) Title of Class of Securities:

Common Stock.

 

Item 2(e) CUSIP Number:

46071F103

 

Item 3 If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

 

                      (a)   ¨    Broker or dealer registered under Section 15 of the Act.
  (b)   ¨    Bank as defined in Section 3(a)(6) of the Act.
  (c)   ¨    Insurance company as defined in Section 3(a)(19) of the Act.
  (d)   ¨    Investment company registered under Section 8 of the Investment Company Act of 1940.
  (e)   ¨    An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E).


CUSIP No. 46071F103    Page 4 of 5 Pages

 

  (f)   ¨    An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F).
                      (g)   ¨    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G).
  (h)   ¨    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
  (i)   ¨    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.
  (j)   ¨    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
  (k)   ¨    Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:                    

 

Item 4 Ownership

See Cover Pages, Items 5 through 11.

 

Item 5 Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ¨.

 

Item 6 Ownership of More than Five Percent on Behalf of Another Person:

Not applicable.

 

Item 7 Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

Not applicable.

 

Item 8 Identification and Classification of Members of the Group:

Not applicable.

 

Item 9 Notice of Dissolution of Group:

Not applicable.

 

Item 10 Certifications:

Not applicable.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: January 23, 2015

 

/s/ Gary Ellis

Name: Gary Ellis

Title: Executive Vice President and Chief Financial Officer